The Cubase Mission

Watch a short video of our CEO, Malte Kuhnemund, discussing why organoids and 3D cell culture models are revolutionizing the industry. From a legislative perspective, these new approach methodologies (NAMs) are on the verge of being routinely used in pre-clinical testing environments.